DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
Authors
Keywords
DPP-4, Inflammation, GLP-1, PKC
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 28, Issue 5, Pages 425-432
Publisher
Springer Nature
Online
2014-07-14
DOI
10.1007/s10557-014-6539-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PKCβ Promotes Vascular Inflammation and Acceleration of Atherosclerosis in Diabetic ApoE Null Mice
- (2013) Linghua Kong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ
- (2013) Yao Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells
- (2013) Yao Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glucagon-like Peptide-1 Receptor Agonist Liraglutide Inhibits Endothelin-1 in Endothelial Cell by Repressing Nuclear Factor-Kappa B Activation
- (2013) Yao Dai et al. CARDIOVASCULAR DRUGS AND THERAPY
- Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis
- (2013) Anna M. Lundberg et al. CARDIOVASCULAR RESEARCH
- Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
- (2013) Junichi Matsubara et al. CIRCULATION JOURNAL
- Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis—evaluations in vitro and in the rat critical limb ischemia model
- (2013) Sarah Chua et al. CYTOTHERAPY
- Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
- (2013) Nasib Ervinna et al. ENDOCRINOLOGY
- Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages
- (2013) Iryna Voloshyna et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation
- (2013) Weiwei Liu et al. INFLAMMATION RESEARCH
- TLR4/PKC-mediated tight junction modulation: A clinical marker of chemotherapy-induced gut toxicity?
- (2013) Hannah R. Wardill et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammation and Atherosclerosis—Revisited
- (2013) Sadip Pant et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
- (2013) Michishige Terasaki et al. PLoS One
- NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation
- (2013) T Satoh et al. Cell Death & Disease
- Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression
- (2012) Miry Blich et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation
- (2012) Yugang Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
- (2012) Mitsuyoshi Namba et al. Clinical and Experimental Nephrology
- Effect of the interleukin-1B gene on serum oxidized low-density lipoprotein levels
- (2012) Maria Fernanda Manica-Cattani et al. CLINICAL BIOCHEMISTRY
- Cardiovascular effects of the DPP-4 inhibitors
- (2012) Tessey Jose et al. Diabetes & Vascular Disease Research
- ABCA1 Protein Enhances Toll-like Receptor 4 (TLR4)-stimulated Interleukin-10 (IL-10) Secretion through Protein Kinase A (PKA) Activation
- (2012) Loretta Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through toll-like receptor-4
- (2012) Rui Liu et al. MOLECULES AND CELLS
- Phosphorylation of NLRC4 is critical for inflammasome activation
- (2012) Yan Qu et al. NATURE
- Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients
- (2011) Paul A. J. Krijnen et al. BASIC RESEARCH IN CARDIOLOGY
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Ht31, a Protein Kinase A Anchoring Inhibitor, Induces Robust Cholesterol Efflux and Reverses Macrophage Foam Cell Formation through ATP-binding Cassette Transporter A1
- (2010) Loretta Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis
- (2008) Yasushi Ishigaki et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started